Tofacitinib versus methotrexate in rheumatoid arthritis: patient-reported outcomes from the randomised phase III ORAL Start trial
about
Tofacitinib: A Review in Rheumatoid Arthritis.Tofacitinib with conventional synthetic disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis: Patient-reported outcomes from a Phase 3 randomized controlled trial.JAK inhibition as a therapeutic strategy for immune and inflammatory diseases.Understanding the different relationships between mood and sleep disorders in several groups of non-oncological patients with chronic pain.JAK inhibition as a therapeutic strategy for immune and inflammatory diseases.Evaluation of disease activity in patients with rheumatoid arthritis treated with tofacitinib by RAPID3: post hoc analyses from two phase 3 trials.Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies.Efficacy of Monotherapy with Biologics and JAK Inhibitors for the Treatment of Rheumatoid Arthritis: A Systematic ReviewIncreased Binding of Specificity Protein 1 to the Promoter in B Cells Results in Enhanced B Cell Responses in Rheumatoid Arthritis
P2860
Q43280727-468F8A33-CD54-4D8B-9041-4CFF1901D267Q47191075-76F13346-1407-41DC-A3E9-8D1947A9A6E0Q47439880-18780EB1-AA1A-4DD4-8A4C-8B8D840D8DB4Q47614319-CD6740DF-BC59-4B1C-ACB9-E710617A9C3EQ48556502-6688C32D-C5D0-4B4E-B18B-F0B95C3E90A5Q52587852-A8C8D8A3-66AA-43A9-9959-6D5702813097Q55025616-C45AAD03-D227-4831-9997-C8DD876537A8Q58732393-66553516-E0C4-4F2B-963A-6FFA8F043A10Q58762971-02240782-F346-4AF5-B79B-F9720ECDF16D
P2860
Tofacitinib versus methotrexate in rheumatoid arthritis: patient-reported outcomes from the randomised phase III ORAL Start trial
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tofacitinib versus methotrexat ...... sed phase III ORAL Start trial
@en
Tofacitinib versus methotrexat ...... ed phase III ORAL Start trial.
@nl
type
label
Tofacitinib versus methotrexat ...... sed phase III ORAL Start trial
@en
Tofacitinib versus methotrexat ...... ed phase III ORAL Start trial.
@nl
prefLabel
Tofacitinib versus methotrexat ...... sed phase III ORAL Start trial
@en
Tofacitinib versus methotrexat ...... ed phase III ORAL Start trial.
@nl
P2093
P2860
P1433
P1476
Tofacitinib versus methotrexat ...... sed phase III ORAL Start trial
@en
P2093
Bethanie Wilkinson
David Gruben
Eun Bong Lee
Gene Wallenstein
Roy Fleischmann
Samuel H Zwillich
Sriram Krishnaswami
Tamas Koncz
Vibeke Strand
P2860
P304
P356
10.1136/RMDOPEN-2016-000308
P50
P577
2016-09-28T00:00:00Z